Nifty
Sensex
:
:
17094.35
57426.92
276.25 (1.64%)
1016.96 (1.80%)

Pharmaceuticals & Drugs - API

Rating :
35/99

BSE: 524164 | NSE: IOLCP

350.60
30-Sep-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 345.70
  • 353.00
  • 344.00
  • 345.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  118764
  •  414.44
  •  624.00
  •  292.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,052.34
  • 15.37
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,955.10
  • 1.14%
  • 1.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.69%
  • 19.71%
  • 31.16%
  • FII
  • DII
  • Others
  • 2.5%
  • 0.02%
  • 2.92%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.32
  • 17.30
  • 4.86

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.15
  • 16.48
  • -14.89

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 59.14
  • 43.00
  • -22.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.88
  • 9.58
  • 8.94

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.73
  • 2.73
  • 2.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.42
  • 5.81
  • 5.30

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
565.01
0.00
0
572.49
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
509.22
0.00
0
527.36
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
55.79
0.00
0
45.13
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
9.87%
0.00%
7.88%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
5.16
0.00
0
6.93
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
3.38
0.00
0
2.34
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
10.98
0.00
0
11.01
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
46.59
0.00
0
38.71
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
11.92
0.00
0
8.95
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
34.67
0.00
0
29.76
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
6.14%
0.00%
5.20%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
5.91
0.00
0
5.07
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 22
Net Sales
-
2,184.02
Net Sales Growth
-
 
Cost Of Goods Sold
-
1,570.51
Gross Profit
-
613.51
GP Margin
-
28.09%
Total Expenditure
-
1,925.73
Power & Fuel Cost
-
78.18
% Of Sales
-
3.58%
Employee Cost
-
141.30
% Of Sales
-
6.47%
Manufacturing Exp.
-
36.86
% Of Sales
-
1.69%
General & Admin Exp.
-
5.12
% Of Sales
-
0.23%
Selling & Distn. Exp.
-
66.84
% Of Sales
-
3.06%
Miscellaneous Exp.
-
26.92
% Of Sales
-
1.23%
EBITDA
-
258.29
EBITDA Margin
-
11.83%
Other Income
-
32.04
Interest
-
8.29
Depreciation
-
43.26
PBT
-
238.78
Tax
-
57.18
Tax Rate
-
25.43%
PAT
-
167.67
PAT before Minority Interest
-
167.67
Minority Interest
-
0.00
PAT Margin
-
7.68%
PAT Growth
-
 
EPS
-
28.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Shareholder's Funds
1,392.28
Share Capital
58.71
Total Reserves
1,333.57
Non-Current Liabilities
56.62
Secured Loans
0.00
Unsecured Loans
0.00
Long Term Provisions
3.01
Current Liabilities
575.29
Trade Payables
409.29
Other Current Liabilities
54.02
Short Term Borrowings
42.75
Short Term Provisions
69.23
Total Liabilities
2,024.19
Net Block
560.64
Gross Block
762.84
Accumulated Depreciation
202.20
Non Current Assets
881.48
Capital Work in Progress
105.20
Non Current Investment
0.00
Long Term Loans & Adv.
6.14
Other Non Current Assets
209.50
Current Assets
1,142.71
Current Investments
2.37
Inventories
409.89
Sundry Debtors
469.80
Cash & Bank
139.99
Other Current Assets
120.66
Short Term Loans & Adv.
89.67
Net Current Assets
567.42
Total Assets
2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Cash From Operating Activity
93.05
PBT
224.85
Adjustment
33.12
Changes in Working Capital
-102.34
Cash after chg. in Working capital
155.63
Interest Paid
0.00
Tax Paid
-62.58
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
-120.19
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
-1.64
Net Cash Inflow / Outflow
-28.78
Opening Cash & Equivalents
32.34
Closing Cash & Equivalent
3.56

Financial Ratios

Standalone /

Consolidated
Description
Mar 22
Book Value (Rs.)
237.15
ROA
8.28%
ROE
12.04%
ROCE
16.25%
Fixed Asset Turnover
2.86
Receivable days
78.51
Inventory Days
68.50
Payable days
95.12
Cash Conversion Cycle
51.89
Total Debt/Equity
0.03
Interest Cover
28.12

News Update:


  • IOL Chemicals and Pharmaceuticals gets nod to invest $2.1 million in USpharma
    23rd Sep 2022, 11:38 AM

    The Board of Directors in its meeting held on September 22, 2022 has inter alia considered and approved the same

    Read More
  • IOL Chemicals and Pharmaceuticals inks pact with Adfactors PR
    17th Sep 2022, 10:15 AM

    The agreement is for providing Public and Investors Relations Services to Adfactors PR

    Read More
  • IOL Chem & Pharma - Quarterly Results
    9th Aug 2022, 20:06 PM

    Read More
  • IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary
    29th Jun 2022, 09:10 AM

    The wholly owned subsidiary is incorporated to carry on the business in the field of Chemicals

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.